Protective effect of ligustrazine on accelerated anti-glomerular basement membrane antibody nephritis in rats is based on its antioxidant properties

European Journal of Pharmacology

Volumn 563, Issue 1-3, 2007, Pages 197-202

  Fu, Hong ^a   Li, Jing ^b   Li, Qi xiong ^a   Xia, Lin ^b   Shao, Lang ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

(Rat); Antioxidants; Effect; Ligustrazine; Nephritis

Indexed keywords

CATALASE; CREATININE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TETRAMETHYLPYRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GLOMERULAR DYSFUNCTION; GLOMERULONEPHRITIS; KIDNEY PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RABBIT; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES; ANTIOXIDANTS; BLOOD UREA NITROGEN; CATALASE; CREATININE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; GLUTATHIONE PEROXIDASE; KIDNEY; MALE; MALONDIALDEHYDE; PROTEINURIA; PYRAZINES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 34247096586     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.015     Document Type: Article

References (36)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
2. Allison A.E., Lorinda M., McCulloch A.A., and Jennifer. Intraglomerular leukocyte recruitment during nephrotoxic serum nephritis in rats. Clin. Immunol. Immunopathol. 57 (1990) 441-458
3. Bergamini C.M., and Seghieri G. ROS and kidney disease in the evolution from acute phase to chronic end stage disease. Free Radic. Biol. Med. 41 (2006) 190-192
4. Beutler E., Durom O., and Kelly B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61 (1963) 882-888
5. Boyce N.W., and Holdsworth S.R. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent, direct antibody and complement-induced, cell-independent injury. J. Immunol. 135 (1985) 918-3921
6. Dai X.Z., and Bache R.J. Coronary and systemic hemodynamic effects of tetramethylpyrazine in the dog. J. Cardiovasc. Pharmacol. 7 (1985) 841-849
7. Dobashi K., Ghosh B., Orak J.K., Singh I., and Singh A.K. Kidney ischemia-reperfusion: modulation of antioxidant defenses. Mol. Cell. Biochem. 205 (2000) 1-11
8. Feng L., Xiong Y., Cheng F., Zhang L., Li S., and Li Y. Effect of ligustrazine on ischemia-reperfusion injury in murine kidney. Transplant. Proc. 36 (2004) 1949-1951
9. Flohe L., and Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 105 (1984) 114-121
10. Fujimoto T., Okada M., Kondo Y., and Tada T. The nature of masugi nephritis histopathological and immunopathological studies. Acta Pathol. Jpn. 14 (1964) 275-310
11. Gunther Z., Gunter W., Saskia S., and Rolf A.K. Inhibition of platelet-derived growth factor-induced mesangial cell proliferation by cyclooxygenase-2 overexpression is abolished through reactive oxygen species. FEBS Lett. 580 (2006) 2523-2528
12. Hammer D.K., and Dixon F.J. Immunologic events in the pathogenesis of nephrotoxic serum nephritis in the rat. J. Exp. Med. 117 (1963) 1019-1042
13. Hattori T., Nagamatsu T., Ito M., and Zusuki Y. Contribution of ID-1- and CD-8-positive cells to the development of crescentic-type anti-GBM nephritis in rats. Nippon Jinzo Gakkaishi 36 (1994) 1228-1239
14. Huang L.C., and Zhan F. Effects of tetramethylpyrazine and prednisone on 38 cases of nephritic syndrome. Chin. J. Integr. Tradit. West. Med. 4 (1998) 51-52
15. Jolanta K., Kelly D., Smith E.A., and Charles. Recent advances in glomerulonephritis. Curr. Diagn. Pathol. 13 (2007) 32-42
16. Koryakova N.N., Rozhdestvenskaya E.D., Kazantseva S.V., Bushueva T.V., and Valamina I.E. Features of a cytokine profile in patients with chronic glomerulonephritis with progressive chronic renal failure. Ter. Arh. 78 (2006) 14-17
17. Krakower C.A., and Greenspon S.A. Localization of the nephrotoxic antigen within the isolated renal glomerulus. AMA Arch. Pathol. 51 (1951) 629-639
18. Li L.L., Zhang Z.R., Gong T., He L.L., and Deng L. Simultaneous determination of Gastrodin and Ligustrazine hydrochloride in dog plasma by gradient high-performance liquid chromatography. J. Pharm. Biomed. Anal. 41 (2006) 1083-1087
19. Liu C.F., Lin M.H., Lin C.C., and Chang H.W. Protective effect of tetramethylpyrazine on absolute ethanol-induced renal toxicity in mice. J. Biomed. Sci. 9 (2002) 299-302
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. Misra H.P., and Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide-dismutase. J. Biol. Chem. 247 (1972) 3170-3175
22. Nagao T., Nagamatsu T., and Suzuki Y. Effect of lipo-prostaglandin E on crescentic-type anti-glomerular-basement membrane nephritis in rats. Eur. J. Pharmacol. 348 (1998) 37-44
23. Narsipur S.S., Peterson O.W., Smith R., Bigby T.D., Parthasarathy S., Gabbai F.B., Wilson C.B., and Blantz R.C. Mechanisms of Glomerular Immune Injury: Effects of Antioxidant Treatment. J. Am. Soc. Nephrol. 14 (2003) 1748-1755
24. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
25. Park S.Y., Ueda H., Ohno Y., Hamano M., Tanaka T., Shiratori T., Yamazaki H., Arase N., and Arase A. Resistance of Fc receptor-deficient mice to fatal. glomerulonephritis. J. Clin. Invest. 102 (1998) 1229-1238
26. Pierina D.M., Rossana F., Pietro F., Antonio M., Alessandro C., Gordiano C., Maria G.M., Andrea S., Aldo C., Giovanni M.S., and Gian M.C. Urinary transforming growth factor-beta1 in various types of nephropathy. Pharmacol. Res. 49 (2004) 293-298
27. Salant D.J., and Cybulsky A.V. Experimental glomerulonephritis. Methods Enzymol. 162 (1988) 421-461
28. Sun L., Li Y., Shi J., and Wang X. Protective effects of ligustrazine on ischemia-reperfusion injury in rat kidneys. Microsurgery 22 (2002) 343-346
29. Tang X. Effect of ligustrazine on proliferative glomerulonephritis. Chin. Herb. Drugs 26 (2003) 611-612
30. Tsai C.C., Lai T.Y., Huang W.C., Liu I.M., and Cheng J.T. Inhibitory effects of potassium channel blockers on tetramethylpyrazine-induced relaxation of aortic strip in vitro. Life Sci. 71 (2002) 1321- 1330
31. Unanue E.R., and Dixon F.J. Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv. Immunol. 6 (1967) 1-90
32. Wada T., Yokoyama H., Furuichi K., Kobayashi K., Harada K., Naruto M., Su S.B., Akiyama M., Mukaida N., and Matsushima K. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J. 10 (1996) 1418 -1425
33. Wang H., Chen L., Zhang Z., Jiang F., and Guo M. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis. Exp. Mol. Pathol. 78 (2005) 17-24
34. Yingwei W., Qiuzhao H., Huilian Q., Jinghua X., Jianxia T., Lingjuan G., and Juan X. The complement C5b-9 complexes induced injury of glomerular mesangial cells in rats with Thy-1 nephritis by increasing nitric oxide synthesis. Life Sci. 79 (2006) 182-192
35. Zhao C., and Ming-Hui Z.T. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin. Immunol. 116 (2005) 77-82
36. Zou L.Y., Hao X.M., Zhang G.Q., Zhang M., Guo J.H., and Liu T.F. Effect of tetramethyl pyrazine on L-type calcium channel in rat ventricular myocytes. Can. J. Physiol. Pharm. 79 (2001) 621-626